The National Institutes of
Health Center for Scientific Review has chosen UT Arlington assistant biology
professor Julian Hurdle to serve on a prestigious study section, one of the
bodies that reviews grant applications, makes recommendations and surveys the
status of research in a particular field.
Hurdle, a specialist in molecular microbiology and
bacterial infectious diseases, will serve on the Drug Discovery and Mechanisms
of Antimicrobial Resistance Study Section through June 30, 2017.
Hurdle is an accomplished researcher who is working hard to build a better
understanding of the role bacteria play in disease,” said Pamela Jansma, dean
of the UT Arlington College of Science. “We are pleased to see him recognized
by his colleagues and take on this active role in helping to determine where
important research funding flows.”
Hurdle joined the UT Arlington
College of Science in 2010 and, in 2011, he was awarded a five-year, $1.9
million research grant from the National Institutes of Health National Center
for Complementary and Alternative Medicine.
“I am honored to be selected,”
said Hurdle. “The study section where I will serve is made up of leading
experts from academia and the pharmaceutical industry and I am looking forward
to contributing to the grant review process.”
section members are chosen based on their demonstrated competence and
achievements in their study area, including activities such as research
activity and publication in scientific journals. Hurdle is using his grant
funding to develop a treatment for C.
difficile, one of the most widespread and dangerous infections in the U.S.
He is working with colleagues at St. Jude Children’s Hospital in Memphis, Tenn.
The University of Texas at Arlington is a comprehensive
research institution of more than 33,800 students and more than 2,200 faculty
members in the heart of North Texas. Visit www.uta.edu to